The Wolf's Howl is a place where we highlight what’s going on in the world of molecular diagnostic laboratory commercialization and reimbursement strategies on topics that are important to you.
About The Author
Ms Wolf is a nationally recognized expert in the field of laboratory commercialization and reimbursement, with over 20 years of experience in the diagnostic laboratory industry, specializing in Molecular Diagnostic Laboratories. She lectures extensively on these topics and has consulted for major laboratories and laboratory associations throughout the U.S.
Ms. Wolf has demonstrated the ability to develop commercial strategies and policies that are designed to enhance revenue from personalized medicine services. Rina has held executive level positions with Molecular Diagnostic Labs such as Axial Biotech, Redpath Integrated Pathology Inc, Genomic Health, and Esoterix to develop reimbursement strategies and programs that led to positive coverage policies with major Third Party Payors. She is a former President and board member of the California Clinical Laboratory Association and is an active participant with ACLA and the Personalized Medicine Coalition. Ms. Wolf has also testified to the Small Business Committee of the U.S. House of Representatives on the impact of CMS billing regulations on Personalized Medicine.
Today Rina holds the position XIFIN’s Vice President, Commercialization Strategies, Consulting & Industry Affairs where she consults with Molecular Diagnostic Laboratories on commercialization and reimbursement strategy.